Ngā hua rapu kaituhi

1

Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer mā Andrea B. Apolo, Neeta Pandit‐Taskar, Michael J. Morris

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Targeted therapies in urothelial carcinoma mā Monalisa Ghosh, Sam J. Brancato, Piyush K. Agarwal, Andrea B. Apolo

I whakaputaina 2014

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Immunotherapy: a new treatment paradigm in bladder cancer mā Nicole N. Davarpanah, Akira Yuno, Jane B. Trepel, Andrea B. Apolo

I whakaputaina 2017

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Trimodality Therapy in Bladder Cancer mā Christopher Premo, Andrea B. Apolo, Piyush K. Agarwal, Deborah E. Citrin

I whakaputaina 2015

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Multimodal management of muscle-invasive bladder cancer mā Jong‐Chul Park, Deborah E. Citrin, Piyush K. Agarwal, Andrea B. Apolo

I whakaputaina 2014

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
6

Magnetic Nanoparticle Mediated Steroid Delivery Mitigates Cisplatin Induced Hearing Loss mā Bharath Ramaswamy, Soumen Roy, Andrea B. Apolo, Benjamin Shapiro, Didier A. Depireux

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Management of adverse events associated with cabozantinib plus nivolumab in renal cell carcinoma: A review mā Bradley A. McGregor, Amir Mortazavi, Lisa M. Cordes, Cristina Salabao, Susan Vandlik, Andrea B. Apolo

I whakaputaina 2021

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
8

Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer mā Andrea B. Apolo, Jamie C. Riches, Heiko Schöder, Oğuz Akın, A. Trout, Matthew I. Milowsky, Dean F. Bajorin

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival mā Juliane Manitz, Sandra P. D’Angelo, Andrea B. Apolo, S. Peter Eggleton, Marcis Bajars, Oliver Bohnsack, James L. Gulley

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Cabozantinib for the treatment of solid tumors: a systematic review mā Pablo Maroto, Camillo Porta, Jaume Capdevila, Andrea B. Apolo, Santiago Viteri, Cristina Rodríguez‐Antona, Lidia Martín, Daniel Castellano

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
11

Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report mā Cecilia Monge, Hoyoung Maeng, Alessandra Brofferio, Andrea B. Apolo, Bharath Sathya, Andrew E. Arai, James L. Gulley, Marijo Bilušić

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Cutaneous Adverse Effects Associated With the Tyrosine-Kinase Inhibitor Cabozantinib mā Rena C. Zuo, Andrea B. Apolo, John J. DiGiovanna, Howard L. Parnes, Corrine Keen, Swati Nanda, William L. Dahut, Edward W. Cowen

I whakaputaina 2014

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Prognostic Model for Predicting Survival of Patients With Metastatic Urothelial Cancer Treated With Cisplatin-Based Chemotherapy mā Andrea B. Apolo, Irina Ostrovnaya, Susan Halabi, Alexia Iasonos, George Philips, Jonathan E. Rosenberg, Jamie C. Riches, Eric J. Small, Matthew I. Milowsky, Dean F. Bajorin

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer mā Vid Leko, Lucas A. McDuffie, Zhili Zheng, Jared J. Gartner, Todd D. Prickett, Andrea B. Apolo, Piyush K. Agarwal, Steven A. Rosenberg, Yong‐Chen Lu

I whakaputaina 2019

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions mā Nick G. Cowan, Yiyi Chen, Tracy M. Downs, Bernard H. Bochner, Andrea B. Apolo, Michael P. Porter, Jeffrey C. La Rochelle, Christopher L. Amling, Theresa M. Koppie

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Tumor-Intrinsic and Tumor-Extrinsic Factors Impacting Hsp90- Targeted Therapy mā Soraya Alarcon, Mehdi Mollapour, M.-J. Lee, Shinji Tsutsumi, S. Lee, Y.S. Kim, Thomas L. Prince, Andrea B. Apolo, Giuseppe Giaccone, Wanping Xu, Len Neckers, Jane B. Trepel

I whakaputaina 2012

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
17

Phase II Study of Gemcitabine, Carboplatin, and Bevacizumab in Patients With Advanced Unresectable or Metastatic Urothelial Cancer mā Arjun Vasant Balar, Andrea B. Apolo, Irina Ostrovnaya, Svetlana Mironov, Alexia Iasonos, A. Trout, Ashley Marie Regazzi, Ilana Garcia-Grossman, David Gallagher, Matthew I. Milowsky, Dean F. Bajorin

I whakaputaina 2013

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Advances in medical imaging for the diagnosis and management of common genitourinary cancers mā Mohammadhadi Bagheri, Mark A. Ahlman, Liza Lindenberg, Barış Türkbey, Jeffrey Lin, A. Cahid Civelek, Ashkan A. Malayeri, Piyush K. Agarwal, Peter L. Choyke, Les Folio, Andrea B. Apolo

I whakaputaina 2017

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
19

Patient-reported outcomes with first-line nivolumab plus cabozantinib versus sunitinib in patients with advanced renal cell carcinoma treated in CheckMate 9ER: an open-label, rando... mā David Cella, Robert J. Motzer, Cristina Suárez, Steven I. Blum, Flavia Ejzykowicz, Melissa Hamilton, Joel Wallace, Burçin Şimşek, Joshua Zhang, Cristina Ivanescu, Andrea B. Apolo, Toni K. Choueiri

I whakaputaina 2022

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies mā Carl Noble, Sapna Gangaputra, Ian Thompson, Amy Yuan, Andrea B. Apolo, Jung‐Min Lee, George N. Papaliodis, Shilpa Kodati, Rachel Bishop, M. Teresa Magone, Lucia Sobrin, H. Nida Sen

I whakaputaina 2019

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Andrea B. Apolo

Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer mā Andrea B. Apolo, Neeta Pandit‐Taskar, Michael J. Morris

Targeted therapies in urothelial carcinoma mā Monalisa Ghosh, Sam J. Brancato, Piyush K. Agarwal, Andrea B. Apolo

Immunotherapy: a new treatment paradigm in bladder cancer mā Nicole N. Davarpanah, Akira Yuno, Jane B. Trepel, Andrea B. Apolo

Trimodality Therapy in Bladder Cancer mā Christopher Premo, Andrea B. Apolo, Piyush K. Agarwal, Deborah E. Citrin

Multimodal management of muscle-invasive bladder cancer mā Jong‐Chul Park, Deborah E. Citrin, Piyush K. Agarwal, Andrea B. Apolo

Magnetic Nanoparticle Mediated Steroid Delivery Mitigates Cisplatin Induced Hearing Loss mā Bharath Ramaswamy, Soumen Roy, Andrea B. Apolo, Benjamin Shapiro, Didier A. Depireux

Management of adverse events associated with cabozantinib plus nivolumab in renal cell carcinoma: A review mā Bradley A. McGregor, Amir Mortazavi, Lisa M. Cordes, Cristina Salabao, Susan Vandlik, Andrea B. Apolo

Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer mā Andrea B. Apolo, Jamie C. Riches, Heiko Schöder, Oğuz Akın, A. Trout, Matthew I. Milowsky, Dean F. Bajorin

Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival mā Juliane Manitz, Sandra P. D’Angelo, Andrea B. Apolo, S. Peter Eggleton, Marcis Bajars, Oliver Bohnsack, James L. Gulley

Cabozantinib for the treatment of solid tumors: a systematic review mā Pablo Maroto, Camillo Porta, Jaume Capdevila, Andrea B. Apolo, Santiago Viteri, Cristina Rodríguez‐Antona, Lidia Martín, Daniel Castellano

Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report mā Cecilia Monge, Hoyoung Maeng, Alessandra Brofferio, Andrea B. Apolo, Bharath Sathya, Andrew E. Arai, James L. Gulley, Marijo Bilušić

Cutaneous Adverse Effects Associated With the Tyrosine-Kinase Inhibitor Cabozantinib mā Rena C. Zuo, Andrea B. Apolo, John J. DiGiovanna, Howard L. Parnes, Corrine Keen, Swati Nanda, William L. Dahut, Edward W. Cowen

Identification of Neoantigen-Reactive Tumor-Infiltrating Lymphocytes in Primary Bladder Cancer mā Vid Leko, Lucas A. McDuffie, Zhili Zheng, Jared J. Gartner, Todd D. Prickett, Andrea B. Apolo, Piyush K. Agarwal, Steven A. Rosenberg, Yong‐Chen Lu

Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions mā Nick G. Cowan, Yiyi Chen, Tracy M. Downs, Bernard H. Bochner, Andrea B. Apolo, Michael P. Porter, Jeffrey C. La Rochelle, Christopher L. Amling, Theresa M. Koppie

Tumor-Intrinsic and Tumor-Extrinsic Factors Impacting Hsp90- Targeted Therapy mā Soraya Alarcon, Mehdi Mollapour, M.-J. Lee, Shinji Tsutsumi, S. Lee, Y.S. Kim, Thomas L. Prince, Andrea B. Apolo, Giuseppe Giaccone, Wanping Xu, Len Neckers, Jane B. Trepel

Advances in medical imaging for the diagnosis and management of common genitourinary cancers mā Mohammadhadi Bagheri, Mark A. Ahlman, Liza Lindenberg, Barış Türkbey, Jeffrey Lin, A. Cahid Civelek, Ashkan A. Malayeri, Piyush K. Agarwal, Peter L. Choyke, Les Folio, Andrea B. Apolo

Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies mā Carl Noble, Sapna Gangaputra, Ian Thompson, Amy Yuan, Andrea B. Apolo, Jung‐Min Lee, George N. Papaliodis, Shilpa Kodati, Rachel Bishop, M. Teresa Magone, Lucia Sobrin, H. Nida Sen

Ngā utauta rapu:

Ngā marau whai pānga